Stockreport

US FDA approves expanded use of Mirum's liver disease drug [Reuters]

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report
PDF new tab oral drug to treat itching caused by a liver disorder in patients aged five years and older, the company said on Wednesday. The company's shares rose 6% to $29 [Read more]